Select the drug indication to add to your list


Pigmentation disorders
Only 4 drugs may be compared at once

Generic Name and Formulations:

Hydroquinone 4%, fluocinolone acetonide 0.01%, tretinoin 0.05%; crm; contains sulfites, parabens.

Select therapeutic use:

Indications for TRI-LUMA:

Short-term intermittent treatment of moderate to severe melasma of the face, with measures for sun avoidance including sunscreen use (SPF 30).


Clean (use a mild, soap-free cleanser) and dry skin. Apply a thin film to affected area(s) and to ½ inch of surrounding normal skin once daily, at least 30 minutes before bedtime.


Not recommended.


Do not occlude or use on eczema or sunburned skin. Avoid eyes, ears, mouth, angle of nose, mucous membranes, sun, UV light. Skin types V and VI (possible undesirable excessive bleaching). Discontinue if ochronosis, chemical irritation, hypersensitivity, or HPA axis suppression occurs. Increased irritation in extreme weather. Elderly. Pregnancy (Cat.C), nursing mothers: consider delaying use until after pregnancy/nursing.


Avoid photosensitizers, topical irritants, and drying agents.

Pharmacological Class:

Skin depigmenting agent + topical steroid + retinoid.

Adverse Reactions:

Local irritation (erythema, peeling, burning, dryness, pruritus), acne, paresthesia, telangiectasia, hyperesthesia, folliculitis, dermatitis, secondary infection, hypertrichosis, skin atrophy, striae, miliaria, HPA axis suppression.

How Supplied:


TRI-LUMA 30g of 0.05% tube of creams (Qty:1)

appx. price $188.00